Lymphoma Trial, Recruiting NCT07305337 Sponsor: Zhongnan Hospital Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07305337
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and are fully alert and aware of your surroundings
  • You have been diagnosed with a blood cancer (such as leukaemia, lymphoma, or a similar condition) that meets recognised medical guidelines for treatment
  • You are able to understand health education information and can communicate in a basic way
  • You are willing to take part in the study and sign a consent form agreeing to participate

Who may not be able to join:

  • People who have memory or thinking difficulties, mental health conditions, or other problems that seriously affect their ability to understand information
  • People whose hospital stay is expected to be shorter than 3 days, as this would not allow enough time to complete the programme
  • People who are receiving end-of-life care focused on comfort rather than active treatment
  • People who have previously taken part in another clinical trial that included an education programme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fuling Fu Zhou, Zhongnan Hospital of Wuhan Universty

Phone: 027-67813137

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongnan Hospital
Registry
ClinicalTrials.gov
Start date
28 June 2025
Est. completion
28 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

intention to participate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov